In November, GSK Romania announced the completion of a $7 million investment in two production lines in the company’s plant in Brasov, to increase production of drugs for exports from 60% to 74% in 2012.
GSK has invested more than $141 million in Romania over the past 13 years, including around $106 million in the Brasov plant, which exports to 80 countries.
This year, the company aims to continue its investments in Romania. GSK hopes the legal and economic framework will be more favorable to such plans, through greater transparency, stability and predictability, general manager Pascal Prigent said in a press release.